TY - JOUR
T1 - Fitbeat
T2 - COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder
AU - Liu, Shuo
AU - Han, Jing
AU - Puyal, Estela Laporta
AU - Kontaxis, Spyridon
AU - Sun, Shaoxiong
AU - Locatelli, Patrick
AU - Dineley, Judith
AU - Pokorny, Florian B.
AU - Costa, Gloria Dalla
AU - Leocani, Letizia
AU - Guerrero, Ana Isabel
AU - Nos, Carlos
AU - Zabalza, Ana
AU - Sørensen, Per Soelberg
AU - Buron, Mathias
AU - Magyari, Melinda
AU - Ranjan, Yatharth
AU - Rashid, Zulqarnain
AU - Conde, Pauline
AU - Stewart, Callum
AU - Folarin, Amos A.
AU - Dobson, Richard JB
AU - Bailón, Raquel
AU - Vairavan, Srinivasan
AU - Cummins, Nicholas
AU - Narayan, Vaibhav A.
AU - Hotopf, Matthew
AU - Comi, Giancarlo
AU - Schuller, Björn
AU - Consortium, RADAR A.D.A.R.C.N.S.
N1 - Funding Information:
This project has received funding from the Innovative Medicines Initiative 6 1 2 Joint Undertaking under grant agreement No 115902. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. This communication reflects the views of the RADAR-CNS consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.
Funding Information:
This project has received funding from the Innovative Medicines Initiative 6 2 Joint Undertaking under grant agreement No 115902. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. This communication reflects the views of the RADAR-CNS consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.
Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2022/3
Y1 - 2022/3
N2 - This study proposes a contrastive convolutional auto-encoder (contrastive CAE), a combined architecture of an auto-encoder and contrastive loss, to identify individuals with suspected COVID-19 infection using heart-rate data from participants with multiple sclerosis (MS) in the ongoing RADAR-CNS mHealth research project. Heart-rate data was remotely collected using a Fitbit wristband. COVID-19 infection was either confirmed through a positive swab test, or inferred through a self-reported set of recognised symptoms of the virus. The contrastive CAE outperforms a conventional convolutional neural network (CNN), a long short-term memory (LSTM) model, and a convolutional auto-encoder without contrastive loss (CAE). On a test set of 19 participants with MS with reported symptoms of COVID-19, each one paired with a participant with MS with no COVID-19 symptoms, the contrastive CAE achieves an unweighted average recall of 95.3%, a sensitivity of 100% and a specificity of 90.6%, an area under the receiver operating characteristic curve (AUC-ROC) of 0.944, indicating a maximum successful detection of symptoms in the given heart rate measurement period, whilst at the same time keeping a low false alarm rate.
AB - This study proposes a contrastive convolutional auto-encoder (contrastive CAE), a combined architecture of an auto-encoder and contrastive loss, to identify individuals with suspected COVID-19 infection using heart-rate data from participants with multiple sclerosis (MS) in the ongoing RADAR-CNS mHealth research project. Heart-rate data was remotely collected using a Fitbit wristband. COVID-19 infection was either confirmed through a positive swab test, or inferred through a self-reported set of recognised symptoms of the virus. The contrastive CAE outperforms a conventional convolutional neural network (CNN), a long short-term memory (LSTM) model, and a convolutional auto-encoder without contrastive loss (CAE). On a test set of 19 participants with MS with reported symptoms of COVID-19, each one paired with a participant with MS with no COVID-19 symptoms, the contrastive CAE achieves an unweighted average recall of 95.3%, a sensitivity of 100% and a specificity of 90.6%, an area under the receiver operating characteristic curve (AUC-ROC) of 0.944, indicating a maximum successful detection of symptoms in the given heart rate measurement period, whilst at the same time keeping a low false alarm rate.
KW - Anomaly detection
KW - Contrastive learning
KW - Convolutional auto-encoder
KW - COVID-19
KW - Respiratory tract infection
UR - http://www.scopus.com/inward/record.url?scp=85118526881&partnerID=8YFLogxK
U2 - 10.1016/j.patcog.2021.108403
DO - 10.1016/j.patcog.2021.108403
M3 - Article
AN - SCOPUS:85118526881
SN - 0031-3203
VL - 123
JO - PATTERN RECOGNITION
JF - PATTERN RECOGNITION
M1 - 108403
ER -